Abstract
The laryngopharyngeal reflex (LPR) is associated with many diseases of the ear, nose, and throat. LPR is characterized by a retrograde flow of gastric contents into the larynx and pharynx, which leads to a recurrent course of otolaryngological symptoms. Proton pump inhibitors (PPIs) are currently the gold standard for LPR. However, there is increasing evidence that not all patients respond satisfactorily to PPIs. 30-35% of patients with LPR require additional intervention to control the symptoms of the disease. Oral probiotics show promise in the treatment of LPR, but evidence is still lacking. Further research is needed to evaluate the impact of oral probiotics on oral, pharyngeal, and laryngeal health.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
